What is iRhythm Technologies?
iRhythm Technologies operates at the intersection of medical device manufacturing and digital health. The company specializes in the development of innovative wearable biosensors that capture continuous cardiac data. By leveraging proprietary algorithms and cloud-based data analytics, iRhythm transforms millions of heartbeats into precise, actionable clinical insights for healthcare providers. This integrated approach facilitates improved disease detection, prediction, and prevention, serving both business-to-business and business-to-consumer markets across North America, Europe, and the Asia-Pacific region.
How much funding has iRhythm Technologies raised?
iRhythm Technologies has raised a total of $337.2M across 10 funding rounds:
Other Financing Round
$10M
Series C
$22M
Private Equity
$12.2M
Debt
$3.5M
Series D
$16M
Series E
$17M
Stock Offering
$123M
Stock Offering
$115M
Other Financing Round (2010): $10M supported by Mohr Davidow Ventures, St. Jude Medical, and Synergy Life Science Partners
Series C (2011): $22M featuring Stanford University, New Leaf Venture Partners, Synergy Life Science Partner, St. Jude Medical, Kaiser Permanente Ventures, and Mohr Davidow Ventures
Private Equity (2012): $12.2M backed by New Leaf Venture Partners, Kaiser Permanente Ventures, Synergy Life Science Partner, and Mohr Davidow Ventures
Debt (2012): $3.5M, investors not publicly disclosed
Series D (2013): $16M led by Kaiser Permanente Ventures, New Leaf Venture Partners, Norwest Venture Partners, and Synergy Life Science Partners
Series E (2014): $17M supported by Novo A/S and Norwest Venture Partners
Stock Issuance/Offering (2016): $123.1M, investors not publicly disclosed
Stock Issuance/Offering (2019): $115M, investors not publicly disclosed
Key Investors in iRhythm Technologies
Kaiser Permanente Ventures
Kaiser Permanente Ventures is a national leader in strategic venture investing in healthcare, focusing on advancing healthcare innovation and integrating new approaches into established delivery systems.
New Leaf Venture Partners
New Leaf Venture Partners is a global venture capital firm dedicated to corporate technology spinouts, providing a systematic process for commercializing innovations in the technology and healthcare sectors.
Mohr Davidow Ventures
Mohr Davidow Ventures specializes in innovative tools aimed at enhancing productivity and streamlining processes, supporting entrepreneurs who recognize significant market opportunities.
What's next for iRhythm Technologies?
With the support of its latest capital injection, iRhythm Technologies is well-positioned to accelerate its strategic roadmap. The company is expected to focus on expanding its digital platform capabilities and deepening its penetration into international healthcare markets. By continuing to refine its machine learning algorithms and enhancing its wearable hardware, iRhythm aims to set new standards in remote patient monitoring. The firm's focus remains on bridging the gap between complex cardiac data and clinical decision-making, ensuring that providers have the tools necessary to deliver high-quality, data-driven patient care in an increasingly digital medical landscape.
See full iRhythm Technologies company page
